Your browser doesn't support javascript.
loading
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
Zhang, Peijing; Wang, Li; Rodriguez-Aguayo, Cristian; Yuan, Yuan; Debeb, Bisrat G; Chen, Dahu; Sun, Yutong; You, M James; Liu, Yongqing; Dean, Douglas C; Woodward, Wendy A; Liang, Han; Yang, Xianbin; Lopez-Berestein, Gabriel; Sood, Anil K; Hu, Ye; Ang, K Kian; Chen, Junjie; Ma, Li.
Afiliación
  • Zhang P; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Wang L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Rodriguez-Aguayo C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Yuan Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Debeb BG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Chen D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Sun Y; Department of Molecular and Cellular Oncology, Houston, Texas 77030, USA.
  • You MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Liu Y; Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, Kentucky 40202, USA.
  • Dean DC; Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, Kentucky 40202, USA.
  • Woodward WA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Liang H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Yang X; AM Biotechnologies, Houston, Texas 77034, USA.
  • Lopez-Berestein G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Sood AK; 1] Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Hu Y; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, USA.
  • Ang KK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Chen J; 1] Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Cancer Biology and Genes &Development Programs, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas 7703
  • Ma L; 1] Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA [2] Cancer Biology and Genes &Development Programs, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas 7703
Nat Commun ; 5: 5671, 2014 Dec 05.
Article en En | MEDLINE | ID: mdl-25476932
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas de Homeodominio / MicroARNs / Enzimas Ubiquitina-Conjugadoras / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas de Homeodominio / MicroARNs / Enzimas Ubiquitina-Conjugadoras / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos